Healthcare -
Biotechnology - NASDAQ - US
$ 12.45
0.161 %
$ 615 M
Market Cap
-3.38
P/E
KALV - OTHER CURRENT LIABILITIES
Other Current Liabilities KALV - KalVista Pharmaceuticals, Inc.
12.4 M
LAST VALUE
33.46%
2 YEAR CAGR
17.26%
5 YEAR CAGR
41.11%
10 YEAR CAGR